CEO says Novartis committed to long-term presence in Slovenia

Ljubljana, 5 July - As Swiss multinational Novartis is seeking to become a leading prescription drugs company, its CEO Vas Narasimhan says it will continue to look to expand its investments in Slovenia as it is committed to its long-term presence here.

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

Ljubljana Swiss multinational Novaris CEO Vas Narasimhan (left) giving an interview for the STA at pharmaceutical company Lek's headquarters. Photo: Nebojša Tejić/STA

Ljubljana
Swiss multinational Novaris CEO Vas Narasimhan (left) giving an interview for the STA at pharmaceutical company Lek's headquarters.
Photo: Nebojša Tejić/STA

The rest of this news item is available to subscribers.
The news item consists of 1.585 characters (without spaces) or 306 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

eho/uk/sm
© STA, 2018